住院肺结核患者体液免疫水平的变化及其临床意义
Effects of chemotherapy on humoral immune of tuberculosis patients and analysis of it’s clinical significance
-
摘要: 本文通过对48例住院化疗肺结核患者的体液免疫水平进行为期4~5个月的监测,发现:接受标准化疗后的肺结核患者产生3种不同的体液免疫反应模式:66.6%的肺结核患者接受化疗后,其血清抗结核IgG抗体在较高水平上持续升高,经1~3个月达到最高值,然后平缓下降;18.7%的肺结核患者在化疗后,其血清特异性IgG抗体维持较高水平,无升高后平缓下降,或在阳性值上下维持不变;还有14.6%的患者,血清特异性抗体水平低,接受化疗后不产生体液免疫反应。有5例肺结核患者其血清特异性抗体水平在观察期间呈现周期性波动。本研究结果表明:化疗作用下结核患者体液免疫增强反应具有保护性效应Abstract: Through the surveilance of humoral immune levels in 48 patients hospitalized with pulmonary tuberculosis under chemotherapy for 4-5 months, it was found that there are three different modes of humoral immune response among the patients after treatment. 66.6% of the patients showed a rising level of antimycobacterial antibodies in thire sera which reached the maxinum after 1-3 month treatment and then decreased slowly, 18.7% of the patients whose sera contained higher level of antimycobacterial antibodies at the beginning of treatment showed a slowly drop in the level of the antibodies after treatment; 14.6% of them whose sera contained low level of specific antibodies had no humoral immune response. The specific antibody levels in five patients during the surveilance period showed a periodic change. The results in the present paper showed that under the effect of chemotherapy the increased humoral immune response may play a protective role.
下载: